deltatrials
Unknown PHASE4 INTERVENTIONAL NCT00134446

Transcranial Magnetic Stimulation for Post-Traumatic Stress Disorder

A Prospective Double Blind Randomized Placebo Controlled Trial of Repetitive Transcranial Magnetic Stimulation for Posttraumatic Stress Disorder

Sponsor: White River Junction Veterans Affairs Medical Center

Updated 6 times since 2017 Last updated: Oct 28, 2005 Started: Mar 31, 2004
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Post-Traumatic Stress Disorders, this trial is ongoing. The trial is conducted by White River Junction Veterans Affairs Medical Center and has accumulated 6 data snapshots since 2004. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Sep 2017 · 8 months · monthly snapshotUnknown Status~Sep 2017 – ~Jun 2018 · 9 months · monthly snapshotUnknown Status~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 23 months · monthly snapshotUnknown

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Unknown PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE4

    Status: Unknown StatusUnknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE4

  5. Sep 2017 — Jun 2018 [monthly]

    Unknown Status PHASE4

Show 1 earlier version
  1. Jan 2017 — Sep 2017 [monthly]

    Unknown Status PHASE4

    First recorded

Mar 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • White River Junction Veterans Affairs Medical Center
Data source: White River Junction Veterans Affairs Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .